Search Results - "ROSSING, PETER"

HbA1c and beyond by Rossing, Peter

“…Abstract The Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on Diabetes Management in Chronic Kidney Disease from 2020 comes at…”
Get full text

Diagnosis of diabetic kidney disease: state of the art and future perspective by Persson, Frederik, Rossing, Peter

“…Approximately 20% to 40% of patients with type 1 or type 2 diabetes mellitus develop diabetic kidney disease. This is a clinical syndrome characterized by…”
Get full text

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) by Buse, John B, Wexler, Deborah J, Tsapas, Apostolos, Rossing, Peter, Mingrone, Geltrude, Mathieu, Chantal, D'Alessio, David A, Davies, Melanie J

“…The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of…”
Get full text

2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) by Buse, John B., Wexler, Deborah J., Tsapas, Apostolos, Rossing, Peter, Mingrone, Geltrude, Mathieu, Chantal, D’Alessio, David A., Davies, Melanie J.

“…The American Diabetes Association and the European Association for the Study of Diabetes have briefly updated their 2018 recommendations on management of…”
Get full text

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) by Davies, Melanie J, D'Alessio, David A, Fradkin, Judith, Kernan, Walter N, Mathieu, Chantal, Mingrone, Geltrude, Rossing, Peter, Tsapas, Apostolos, Wexler, Deborah J, Buse, John B

“…The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in…”
Get full text

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) by Davies, Melanie J, Aroda, Vanita R, Collins, Billy S, Gabbay, Robert A, Green, Jennifer, Maruthur, Nisa M, Rosas, Sylvia E, Del Prato, Stefano, Mathieu, Chantal, Mingrone, Geltrude, Rossing, Peter, Tankova, Tsvetalina, Tsapas, Apostolos, Buse, John B

“…The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the…”
Get full text

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes by Bakris, George L, Agarwal, Rajiv, Anker, Stefan D, Pitt, Bertram, Ruilope, Luis M, Rossing, Peter, Kolkhof, Peter, Nowack, Christina, Schloemer, Patrick, Joseph, Amer, Filippatos, Gerasimos

“…In this double-blind trial, patients with chronic kidney disease and type 2 diabetes were randomly assigned to receive the nonsteroidal, selective…”
Get full text

Successful glucose lowering therapy triumphs in heart failure by Rossing, Peter

Get full text

Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history by Rossing, Peter

“…Diabetic nephropathy has become a worldwide epidemic, accounting for approximately one third of all cases of end-stage renal disease. With increasing…”
Get full text

Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) by de Boer, Ian H, Khunti, Kamlesh, Sadusky, Tami, Tuttle, Katherine R, Neumiller, Joshua J, Rhee, Connie M, Rosas, Sylvia E, Rossing, Peter, Bakris, George

“…People with diabetes and chronic kidney disease (CKD) are at high risk for kidney failure, atherosclerotic cardiovascular disease, heart failure, and premature…”
Get more information

Metformin and cardiorenal outcomes in diabetes: A reappraisal by Petrie, John R., Rossing, Peter R., Campbell, Ian W.

“…The guidance issued to the pharmaceutical industry by the US Food and Drug Administration in 2008 has led to the publication of a series of randomized,…”
Get full text

Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer by Oellgaard, Jens, Winther, Signe Abitz, Hansen, Tobias Schmidt, Rossing, Peter, von Scholten, Bernt Johan

“…The intake of animal products in food has been associated with both the development of insulin resistance and gastrointestinal cancers (GIC). Through the…”
Get more information

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence by Rossing, Peter, Caramori, M Luiza, Chan, Juliana C N, Heerspink, Hiddo J L, Hurst, Clint, Khunti, Kamlesh, Liew, Adrian, Michos, Erin D, Navaneethan, Sankar D, Olowu, Wasiu A, Sadusky, Tami, Tandon, Nikhil, Tuttle, Katherine R, Wanner, Christoph, Wilkens, Katy G, Zoungas, Sophia, Craig, Jonathan C, Tunnicliffe, David J, Tonelli, Marcello A, Cheung, Michael, Earley, Amy, de Boer, Ian H

“…The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a…”
Get more information

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease by Chertow, Glenn M, Vart, Priya, Jongs, Niels, Toto, Robert D, Gorriz, Jose Luis, Hou, Fan Fan, McMurray, John J V, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C David, Stefánsson, Bergur V, Langkilde, Anna Maria, Wheeler, David C, Heerspink, Hiddo J L

“…In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized, placebo-controlled trial, the sodium-glucose…”
Get full text

Stratification of type 2 diabetes based on routine clinical markers by Safai, Narges, Ali, Ashfaq, Rossing, Peter, Ridderstråle, Martin

“…We hypothesized that patients with dysregulated type 2 diabetes may be stratified based on routine clinical markers. In this retrospective cohort study,…”
Get full text

Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline by Navaneethan, Sankar D, Zoungas, Sophia, Caramori, M Luiza, Chan, Juliana C N, Heerspink, Hiddo J L, Hurst, Clint, Liew, Adrian, Michos, Erin D, Olowu, Wasiu A, Sadusky, Tami, Tandon, Nikhil, Tuttle, Katherine R, Wanner, Christoph, Wilkens, Katy G, Lytvyn, Lyubov, Craig, Jonathan C, Tunnicliffe, David J, Howell, Martin, Tonelli, Marcello, Cheung, Michael, Earley, Amy, Rossing, Peter, de Boer, Ian H, Khunti, Kamlesh

“…The Kidney Disease: Improving Global Outcomes (KDIGO) organization developed a clinical practice guideline in 2020 for the management of patients with diabetes…”
Get full text

The effect of liraglutide on renal function: A randomized clinical trial by von Scholten, Bernt J., Persson, Frederik, Rosenlund, Signe, Hovind, Peter, Faber, Jens, Hansen, Tine W., Rossing, Peter

“…Aims Among patients with type 2 diabetes and albuminuria, cardiorenal morbidity and mortality are high despite multifactorial treatment. Short‐term reduction…”
Get full text

Effects of the chymase inhibitor fulacimstat in diabetic kidney disease—results from the CADA DIA trial by Rossing, Peter, Strand, Jorma, Avogaro, Angelo, Becka, Michael, Kanefendt, Friederike, Otto, Christiane

“…Abstract Background The protease chymase generates multiple factors involved in tissue remodelling including angiotensin II (Ang II) and has been implicated in…”
Get full text

Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy by ZÜRBIG, Petra, JERUMS, George, HOVIND, Peter, MACISAAC, Richard J, MISCHAK, Harald, NIELSEN, Stine E, PANAGIOTOPOULOS, Sianna, PERSSON, Frederik, ROSSING, Peter

“…Diabetic nephropathy (DN) is a progressive kidney disease, a well-known complication of long-standing diabetes. DN is the most frequent reason for dialysis in…”
Get full text

Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes by Zampetaki, Anna, Willeit, Peter, Burr, Simon, Yin, Xiaoke, Langley, Sarah R, Kiechl, Stefan, Klein, Ronald, Rossing, Peter, Chaturvedi, Nishi, Mayr, Manuel

“…Circulating microRNAs (miRNAs) have emerged as novel biomarkers of diabetes. The current study focuses on the role of circulating miRNAs in patients with type…”
Get full text